The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global patient safety and risk management software market grew at a CAGR of around 10% during 2015-2020. Looking forward, IMARC Group expects the market to exhibit strong growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Patient safety and risk management software offers innovative tools to protect hospitals against administrative, clinical, and financial losses. It assists in collecting data consistently, adding structure to internal compliance processes, and capturing visitor feedback to manage expectations and resolve concerns timely. It relies on sophisticated analytics to transform complex data into understandable and actionable information. Presently, healthcare institutes worldwide are using patient safety and risk management software to reduce deaths caused by human error and lack of transparency in medical records.
The growing prevalence of chronic conditions and the rising access to healthcare services across the globe are increasing the burden of medical data. This represents one of the key factors escalating the demand for patient safety and risk management software worldwide to collect data, automate processes, and reduce medical errors efficiently and securely. Moreover, the leading players are delivering software via a cloud-based infrastructure to enhance the accuracy, speed, and actionability of data. The rising instances of cybersecurity threats are also positively influencing the demand for cloud-based software to enable organizations to adapt to industry uncertainties, reduce third-party risk and provide quality care, which is fueling the market growth. Apart from this, several companies are integrating big data and smart analytics with extensive support services to streamline data collection, automate communication, and make better strategic decisions. As patient safety and risk management software is flexible, scalable, modular, secure, user-friendly, and can be used anywhere, its demand is anticipated to rise in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global patient safety and risk management software market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on software type, deployment mode and end user.
Breakup by Software Type:
Breakup by Deployment Mode:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Clarity Group Inc., Conduent Inc., Health Catalyst Inc., Medical Information Technology Inc., Prista Corporation, Quantros Inc., Riskonnect Inc., RiskQual Technologies, RLDatix Ltd. and The Patient Safety Company (Symplr).
|Base Year of the Analysis||2020|
|Segment Coverage||Software Type, Deployment Mode, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Clarity Group Inc., Conduent Inc., Health Catalyst Inc., Medical Information Technology Inc., Prista Corporation, Quantros Inc., Riskonnect Inc., RiskQual Technologies, RLDatix Ltd. and The Patient Safety Company (Symplr)|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at